ALR Technologies SG (ALRTF) EBIT Margin (2022)
ALR Technologies SG (ALRTF) posted EBIT Margin of 94758.98% for Q2 2022.
ALR Technologies SG (ALRTF) EBIT Margin (2022) Analysis & Trends
ALR Technologies SG's EBIT Margin history runs 1 years deep, the most recent figure standing at 94758.98% for Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 10.04% |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 6.17% |
| 10 | ALR Technologies SG | 61.20 Mn | 61.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -94,758.98% |